DIA Global Pharmacovigilance and Risk Management Strategies Conference
Conference Focus
Pharmacovigilance, benefit-risk assessment, AI-driven signal detection, real-world evidence
Overview
The DIA Global Pharmacovigilance and Risk Management Strategies Conference is a premier annual event organized by the Drug Information Association (DIA). It serves as a critical forum for global experts to discuss the evolving landscape of drug safety, benefit-risk assessment, and regulatory compliance. The conference is highly significant for its role in bridging the gap between industry, regulators, and academia to address complex safety challenges. This event is unique for its deep focus on integrating emerging technologies like AI-driven signal detection with traditional pharmacovigilance practices. It covers the entire product lifecycle, emphasizing the application of real-world evidence to enhance safety monitoring, risk mitigation strategies, and post-marketing surveillance in an increasingly digital and data-heavy regulatory environment.
Why Attend
Professionals should attend to gain actionable insights into navigating complex global regulatory requirements and implementing advanced safety technologies. The conference offers unparalleled networking with industry peers and regulators, providing a strategic advantage in developing robust risk management plans. Attendees will learn to leverage AI and real-world data to improve safety outcomes, ensuring compliance while accelerating the delivery of safe therapies to patients.
Key Topics & Sessions
- •AI and Machine Learning in Signal Detection
- •Global Regulatory Updates and Compliance
- •Benefit-Risk Assessment Methodologies
- •Real-World Evidence in Safety Surveillance
- •Risk Evaluation and Mitigation Strategies (REMS)
- •Pharmacovigilance Quality Management Systems
- •Patient-Centric Safety Reporting
- •Digital Health and Wearable Data Integration
- •Post-Marketing Safety Studies
- •Pharmacovigilance Outsourcing and Vendor Management
Who Should Attend
Conference History
DIA has been a cornerstone of the pharmaceutical industry for over 60 years, fostering neutral, multidisciplinary collaboration. This specific conference series has long been the definitive annual gathering for the global pharmacovigilance community, consistently adapting to address the industry's shift toward digital transformation and complex global safety regulations.
Venue & Location
Virtual event. The conference utilizes a dedicated digital platform to host live sessions, interactive Q&A, virtual networking lounges, and an on-demand library of recorded content.
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About DIA Global Pharmacovigilance and Risk Management Strategies Conference
DIA Global Pharmacovigilance and Risk Management Strategies Conference is a virtual event scheduled for 2026-01-25 to 2026-01-28 in Virtual (converted from North Bethesda, MD). The conference focuses on pharmacovigilance, benefit-risk assessment, ai-driven signal detection, real-world evidence. This event is categorized under Pharmacovigilance & Drug Safety, AI & Machine Learning in Pharma in our conference directory.
The DIA Global Pharmacovigilance and Risk Management Strategies Conference is a premier annual event organized by the Drug Information Association (DIA). It serves as a critical forum for global experts to discuss the evolving landscape of drug safety, benefit-risk assessment, and regulatory compliance. The conference is highly significant for its role in bridging the gap between industry, regulators, and academia to address complex safety challenges. This event is unique for its deep focus on integrating emerging technologies like AI-driven signal detection with traditional pharmacovigilance practices. It covers the entire product lifecycle, emphasizing the application of real-world evidence to enhance safety monitoring, risk mitigation strategies, and post-marketing surveillance in an increasingly digital and data-heavy regulatory environment.
Professionals attending conferences like DIA Global Pharmacovigilance and Risk Management Strategies Conference gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
AI and machine learning continue to transform the pharmaceutical industry, from drug discovery to commercial operations. Conferences featuring AI content provide valuable exposure to real-world implementations and emerging capabilities. Explore our Pharmaceutical GenAI Tracker for a comprehensive view of AI deployments across the industry.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.